Penserra Capital Management’s Halozyme HALO Stock Holding History

Penserra Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-714	Closed	-$52K	–	1094
2025 Q3	$52K	Buy	+714	New	+$47.4K	﹤0.01%	795
2025 Q2	–	Sell	-1,960	Closed	-$125K	–	1074
2025 Q1	$125K	Buy	+1,960	New	+$114K	﹤0.01%	776
2024 Q4	–	Sell	-4,312	Closed	-$246K	–	1147
2024 Q3	$246K	Buy	4,312 +1,687	+64%	+$96.7K	0.01%	676
2024 Q2	$137K	Buy	+2,625	New	+$115K	﹤0.01%	782
2021 Q4	–	Sell	-3,255	Closed	-$132K	–	1437
2021 Q3	$132K	Buy	3,255 +15	+0.5%	+$627	﹤0.01%	707
2021 Q2	$147K	Buy	3,240 +180	+6%	+$7.97K	﹤0.01%	703
2021 Q1	$127K	Sell	3,060 -70	-2%	-$3.2K	﹤0.01%	655
2020 Q4	$133K	Buy	3,130 +1,958	+167%	+$70.4K	﹤0.01%	580
2020 Q3	$30K	Buy	+1,172	New	+$32.6K	﹤0.01%	691

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Penserra Capital Management's HALO Position: Q4 2025 in Review

Penserra Capital Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 714 shares — an estimated $52K sold.

Penserra Capital Management first reported a position in HALO in Q3 2020 and held it in 9 quarters. The position peaked at $246K in Q3 2024. 619 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

Penserra Capital Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
Penserra Capital Management sold 714 Halozyme shares in Q4 2025, an estimated $52K.
Penserra Capital Management first reported a position in Halozyme in Q3 2020 and held it in 9 quarters.
Penserra Capital Management's Halozyme position peaked at $246K in Q3 2024.
619 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Penserra Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.